Nuvation Bio (NUVB) Accounts Payables (2023 - 2025)
Historic Accounts Payables for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $15.4 million.
- Nuvation Bio's Accounts Payables rose 2407.11% to $15.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.4 million, marking a year-over-year increase of 2407.11%. This contributed to the annual value of $6.3 million for FY2024, which is 18736.99% up from last year.
- Nuvation Bio's Accounts Payables amounted to $15.4 million in Q3 2025, which was up 2407.11% from $22.4 million recorded in Q2 2025.
- Over the past 5 years, Nuvation Bio's Accounts Payables peaked at $22.4 million during Q2 2025, and registered a low of $2.2 million during Q4 2023.
- For the 3-year period, Nuvation Bio's Accounts Payables averaged around $7.7 million, with its median value being $5.2 million (2024).
- Over the last 5 years, Nuvation Bio's Accounts Payables had its largest YoY gain of 42170.25% in 2024, and its largest YoY loss of 1728.35% in 2024.
- Quarter analysis of 3 years shows Nuvation Bio's Accounts Payables stood at $2.2 million in 2023, then skyrocketed by 187.37% to $6.3 million in 2024, then surged by 141.97% to $15.4 million in 2025.
- Its Accounts Payables stands at $15.4 million for Q3 2025, versus $22.4 million for Q2 2025 and $10.5 million for Q1 2025.